2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y(12) Receptor Antagonists in the Asia-Pacific Region

The unique characteristics of patients with acute coronary syndrome in the Asia-Pacific region mean that international guidelines on the use of dual antiplatelet therapy (DAPT) cannot be routinely applied to these populations. Newer generation P2Y(12) inhibitors (i.e. ticagrelor and prasugrel) have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Cardiol
Main Authors: Tan, Jack WC, Chew, Derek P, Abdul Kader, Muhamad Ali SK, Ako, Junya, Bahl, Vinay K, Chan, Mark, Park, Kyung Woo, Chandra, Praveen, Hsieh, I-Chang, Huan, Do Quang, Johar, Sofian, Juzar, Dafsah Arifa, Kim, Byeong-Keuk, Lee, Cheol Whan, Lee, Michael Kang-Yin, Li, Yi-Heng, Almahmeed, Wael, Sison, Eric Oliver, Tan, Doreen, Wang, Yu-Chen, Yeh, Shiuan Jong, Montalescot, Gilles
Formato: Artigo
Idioma:Inglês
Publicado em: Radcliffe Cardiology 2021
Assuntos:
APSC Consensus Statements
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941380/
https://ncbi.nlm.nih.gov/pubmed/33708263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2020.40
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados